Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...
Officials have deemed terms like “immunizations” and “vaccines” risky “buzzwords” that require approval to be used in social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback